Trials / Conditions / Eosinophilic Gastroenteritis

Eosinophilic Gastroenteritis

18 registered clinical trials studyying Eosinophilic Gastroenteritis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis Wit NCT05831176	Regeneron Pharmaceuticals	Phase 2
Completed	A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eos NCT05214768	Celgene	Phase 3
Terminated	Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON NCT05251909	AstraZeneca	Phase 3
Completed	A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis NCT04856891	Allakos Inc.	Phase 3
Completed	Dupilumab in Eosinophilic Gastritis NCT03678545	Children's Hospital Medical Center, Cincinnati	Phase 2
Completed	Examining the Effect of Ondansetron on Bowel Prep Success NCT05439772	State University of New York - Downstate Medical Center	Phase 4
Recruiting	Eosinophilic Gastrointestinal Disorders Registry NCT05199532	Ann & Robert H Lurie Children's Hospital of Chicago	—
Completed	An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis NCT03664960	Allakos Inc.	Phase 2
Completed	A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis NCT03496571	Allakos Inc.	Phase 2
Completed	Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis NCT03320369	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort NCT02897271	Children's Hospital Medical Center, Cincinnati	—
Recruiting	OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118	Children's Hospital Medical Center, Cincinnati	—
Terminated	Sirolimus for Eosinophil-Associated Gastrointestinal Disorders NCT01814059	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Terminated	Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders NCT01212016	National Institute of Allergy and Infectious Diseases (NIAID)	—
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Completed	Montelukast in the Treatment of Duodenal Eosinophilia NCT00148603	Children's Mercy Hospital Kansas City	N/A
Completed	Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome NCT00266565	Children's Hospital Medical Center, Cincinnati	Phase 1 / Phase 2
Completed	Data Bank for Eosinophilic Disorders NCT00267475	Marc Rothenberg	—